Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AUIDNASDAQ:DHNASDAQ:DOMONASDAQ:MTLS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUIDauthID$5.66+2.7%$5.74$4.01▼$10.95$76.07M1.7382,050 shs145,714 shsDHDefinitive Healthcare$3.81+0.5%$3.30$2.15▼$6.16$566.32M1.58803,471 shs2.28 million shsDOMODomo$13.91+0.1%$10.68$6.01▼$14.83$559.74M1.83401,677 shs959,948 shsMTLSMaterialise$5.61+1.1%$5.34$3.93▼$9.69$331.38M1.57185,800 shs63,937 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUIDauthID0.00%+16.22%+4.81%+16.70%-45.47%DHDefinitive Healthcare0.00%+0.26%+14.76%+31.83%-30.22%DOMODomo0.00%+9.53%+10.57%+79.25%+80.18%MTLSMaterialise0.00%+4.08%+4.66%+14.02%+11.98%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAUIDauthID0.5649 of 5 stars0.05.00.00.01.90.00.0DHDefinitive Healthcare1.6356 of 5 stars3.01.00.00.01.52.50.6DOMODomo3.7156 of 5 stars2.22.00.03.32.74.20.6MTLSMaterialise0.9621 of 5 stars0.04.00.00.03.30.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAUIDauthID 0.00N/AN/AN/ADHDefinitive Healthcare 1.90Reduce$5.1033.86% UpsideDOMODomo 2.38Hold$12.17-12.53% DownsideMTLSMaterialise 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AUID, DH, MTLS, and DOMO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025DOMODomoCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform6/25/2025DOMODomoJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Outperform ➝ Market Outperform$16.00 ➝ $20.006/25/2025DOMODomoCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$17.005/22/2025DOMODomoCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/22/2025DOMODomoLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold$8.50 ➝ $9.005/22/2025DOMODomoDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$8.00 ➝ $9.005/22/2025DOMODomoJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$16.00 ➝ $16.005/22/2025DOMODomoCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$11.00 ➝ $12.005/12/2025DHDefinitive HealthcareThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.00 ➝ $3.405/9/2025DHDefinitive HealthcareBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral4/16/2025DOMODomoMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $8.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAUIDauthID$890K85.47N/AN/A$1.05 per share5.39DHDefinitive Healthcare$252.20M2.25$5.29 per share0.72$4.09 per share0.93DOMODomo$317.04M1.77N/AN/A($4.49) per share-3.10MTLSMaterialise$288.70MN/A$0.53 per share10.63$4.55 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAUIDauthID-$14.28M-$1.54N/A∞N/A-1,518.05%-117.29%-100.25%8/6/2025 (Estimated)DHDefinitive Healthcare-$413.12M-$4.39N/A27.216.63-206.05%3.69%2.15%8/4/2025 (Estimated)DOMODomo-$81.93M-$1.89N/AN/AN/A-23.33%N/A-36.37%8/27/2025 (Estimated)MTLSMaterialise$14.54M$0.1733.00∞N/A3.45%3.77%2.35%7/30/2025 (Estimated)Latest AUID, DH, MTLS, and DOMO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2026DOMODomo-$0.19-$0.09+$0.10-$0.45$77.75 million$80.11 million5/13/2025Q1 2025AUIDauthIDN/A-$0.40N/A-$0.40N/AN/A5/8/2025Q1 2025DHDefinitive Healthcare$0.02$0.05+$0.03-$0.95$56.20 million$59.19 million4/24/2025Q1 2025MTLSMaterialise$0.02-$0.01-$0.03-$0.01$67.00 million$71.79 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAUIDauthIDN/AN/AN/AN/AN/ADHDefinitive HealthcareN/AN/AN/AN/AN/ADOMODomoN/AN/AN/AN/AN/AMTLSMaterialiseN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAUIDauthIDN/A2.392.39DHDefinitive Healthcare0.371.751.75DOMODomoN/A0.510.51MTLSMaterialise0.081.881.72Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAUIDauthID8.83%DHDefinitive Healthcare98.67%DOMODomo76.64%MTLSMaterialise19.30%Insider OwnershipCompanyInsider OwnershipAUIDauthID7.20%DHDefinitive Healthcare14.84%DOMODomo15.24%MTLSMaterialiseN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAUIDauthID6013.44 million12.48 millionNot OptionableDHDefinitive Healthcare970148.64 million126.58 millionNot OptionableDOMODomo92040.24 million34.10 millionOptionableMTLSMaterialise2,514N/AN/AOptionableAUID, DH, MTLS, and DOMO HeadlinesRecent News About These CompaniesA Look At The Fair Value Of Materialise NV (NASDAQ:MTLS)June 20, 2025 | finance.yahoo.comHere’s Why Prosper Stars & Stripes Sold Its Stake in Materialise NV (MTLS)June 13, 2025 | insidermonkey.comCantor Fitzgerald Weighs in on Materialise FY2026 EarningsJune 10, 2025 | marketbeat.comShort Interest in Materialise NV (NASDAQ:MTLS) Drops By 19.9%June 2, 2025 | marketbeat.comMaterialise to Hold Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting on June 3, 2025May 16, 2025 | globenewswire.comInvestors in Materialise (NASDAQ:MTLS) have unfortunately lost 73% over the last five yearsMay 10, 2025 | finance.yahoo.comMaterialise: Medical Segment Continues To ThriveMay 7, 2025 | seekingalpha.comMaterialise NV (MTLS): A Bull Case TheoryApril 28, 2025 | insidermonkey.comMaterialise First Quarter 2025 Earnings: €0.009 loss per share (vs €0.061 profit in 1Q 2024)April 27, 2025 | finance.yahoo.comMaterialise NV American Depositary Shares (MTLS)April 25, 2025 | nasdaq.comMaterialise NV (MTLS) Q1 2025 Earnings Call TranscriptApril 24, 2025 | seekingalpha.comMaterialise Reports First Quarter 2025 ResultsApril 24, 2025 | businesswire.comMaterialise Q1 2025 Earnings PreviewApril 23, 2025 | msn.comCollins, Materialise Target Longer-Than-Expected Aircraft Service LifeApril 15, 2025 | aviationweek.comAMaterialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025 | MTLS Stock NewsApril 14, 2025 | gurufocus.comMaterialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025April 14, 2025 | gurufocus.comMaterialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025April 14, 2025 | businesswire.comMaterialise unveils 2025 MagicsApril 11, 2025 | voxelmatters.comVNon-Executive Chairman of Materialise Picks Up 40% More StockMarch 6, 2025 | finance.yahoo.comMaterialise: Manufacturing Headwinds Are A DistractionFebruary 24, 2025 | seekingalpha.comMaterialise NV Beat Analyst Estimates: See What The Consensus Is Forecasting For This YearFebruary 22, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseSoundHound’s AI Growth Story Is Just Getting StartedBy Gabriel Osorio-Mazilli | June 16, 2025View SoundHound’s AI Growth Story Is Just Getting StartedWhy SoundHound Could Be a Short Squeeze in the MakingBy Gabriel Osorio-Mazilli | June 2, 2025View Why SoundHound Could Be a Short Squeeze in the MakingUnitedHealth Stock Dips: Is This a Value Buy Opportunity?By Jeffrey Neal Johnson | June 13, 2025View UnitedHealth Stock Dips: Is This a Value Buy Opportunity?AUID, DH, MTLS, and DOMO Company DescriptionsauthID NASDAQ:AUID$5.66 +0.15 (+2.72%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$5.63 -0.03 (-0.53%) As of 06/27/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.authID Inc. provides secure, biometric, identity verification, and strong passwordless and biometric authentication for consumer and workforce applications worldwide. The company offers solutions through its Verified platform to enable their users to easily verify and authenticate their identity through a mobile device or desktop. It provides Biometric Identity Verification, which establishes the trusted identity of users based on a variety of ground truth sources, including chip-based electronic machine-readable travel documents, national IDs, and driver's licenses; Human Factor Authentication that delivers trusted FIDO2 strong authentication for device-based passwordless login and transaction authentication that is tied to a trusted identity; Cloud-Based Biometric Multi-Factor Authentication, which provides any bank, enterprise, or government department a secure and convenient application for identity verification and transaction consent as part of any type of electronic transaction; and Identity - Portal that enables enterprises to get started with its identity products without any integration. The company also offers SEARCH, a biometric matching software for desktop fingerprint capture and image processing. The company was formerly known as Ipsidy Inc. and changed its name to authID Inc. authID Inc. was founded in 2009 and is headquartered in Denver, Colorado.Definitive Healthcare NASDAQ:DH$3.81 +0.02 (+0.53%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$3.72 -0.09 (-2.36%) As of 06/27/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.Domo NASDAQ:DOMO$13.91 +0.02 (+0.14%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$14.20 +0.30 (+2.12%) As of 06/27/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Domo, Inc., together with its subsidiaries, operates a cloud-based business intelligence platform in North America, Western Europe, Canada, Australia, and Japan. Its platform digitally connects from the chief executive officer to the frontline employee with the various people, data, and systems in an organization, as well as giving them access to real-time data and insights, and allowing them to manage business via various browsers and visualization engines accessible across laptops, TV screens, monitors, tablets, and smartphones. The company was formerly known as Domo Technologies, Inc. and changed its name to Domo, Inc. in December 2011. Domo, Inc. was incorporated in 2010 and is headquartered in American Fork, Utah.Materialise NASDAQ:MTLS$5.61 +0.06 (+1.08%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$5.52 -0.10 (-1.69%) As of 06/27/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
